These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4727846)

  • 1. [Our experiences with the treatment of malignant tumors using fractionated irradiation and synchronization of the mitotic cycle by means of cytostatics].
    Chládek V; Dobiás J
    Cesk Otolaryngol; 1973 Aug; 22(4):242-5. PubMed ID: 4727846
    [No Abstract]   [Full Text] [Related]  

  • 2. Synchronization of human tissues and its consequences for cancer therapy in ENT. Cell kinetic and clinical studies.
    Nitze HR; Ganzer U; Vosteen KH
    Adv Otorhinolaryngol; 1974; 21():82-155. PubMed ID: 4831897
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and experimental studies on radiotherapy of inoperable tumors following partial synchronization].
    Wannenmacher M; Esser E; Glupe J; Schumann J
    Strahlentherapie; 1974 Jan; 147(1):1-9. PubMed ID: 4837640
    [No Abstract]   [Full Text] [Related]  

  • 4. [The permanent, long-term infusion of cytostatics in the treatment of otorhinolaryngological tumors].
    Abrahamovic M; Vojtísek V
    Cesk Otolaryngol; 1966 Oct; 15(5):279-85. PubMed ID: 5976917
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy with or without radiotherapy in patients with locoregionally recurrent nasopharyngeal carcinoma.
    Wong ZW; Tan EH; Yap SP; Tan T; Leong SS; Fong KW; Wee J
    Head Neck; 2002 Jun; 24(6):549-54. PubMed ID: 12112552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined treatment of radiotherapy, neo-adjuvant chemotherapy and adjuvant chemotherapy for nasopharyngeal carcinoma].
    Takamura A; Saito H; Sakurai Y; Horio K; Hatayama N; Hangai K
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):569-71. PubMed ID: 8129404
    [No Abstract]   [Full Text] [Related]  

  • 7. [Various radiobiological aspects of "Synchronization therapy in the treatment of tumors"].
    Trott KR
    Strahlentherapie; 1971 Nov; 142(5):568-74. PubMed ID: 5152060
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment outcome of locally advanced nasopharyngeal cancer with concurrent chemoradiotherapy.
    Yarney J; Vanderpuye V; Kitcher ED
    West Afr J Med; 2008 Apr; 27(2):65-8. PubMed ID: 19025016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intra-arterial regional chemotherapy in the overall treatment of nasopharyngeal tumors].
    Baibakov AB; Liubchak AA
    Zh Ushn Nos Gorl Bolezn; 1974; (3):97-8. PubMed ID: 4446786
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
    Nakamura T; Kodaira T; Tachibana H; Tomita N; Tomoda T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A; Fuwa N
    Jpn J Clin Oncol; 2008 Dec; 38(12):803-9. PubMed ID: 18840881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax.
    Kang SY; Oh YT; Han JH; Choi JH; Lim HY; Kim HI; Lee HW; Jang JH; Park JS; Kim HC; Kang S; Chun M; Kim CH; Joo HJ
    Neoplasma; 2006; 53(5):450-6. PubMed ID: 17013542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined (chemo-radiation) treatment of patients with nasopharyngeal cancer].
    Seriakov AP; Kopychev IuE; Gorbunov VA; Zav'ialov MS; Kubyshkin SI; Smolin AV; Sukirko VA
    Voen Med Zh; 2005 Nov; 326(11):38-43, 111. PubMed ID: 16404906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic plan for malignant nasopharyngeal cancer and its result].
    Inuyama M; Miyake H; Hayasaki H
    Jibiinkoka; 1972 Mar; 44(3):179-88. PubMed ID: 5062808
    [No Abstract]   [Full Text] [Related]  

  • 15. Cisplatin and fluorouracil concurrent to radiotherapy in nasopharyngeal cancer: is the schedule compatible?
    Licitra L; Bossi P; Locati L; Zunino F
    J Clin Oncol; 2004 Jan; 22(2):377; author reply 377-8. PubMed ID: 14722048
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined treatment of tumours of the oto-rhino-laryngeal region by methotrexate and irradiation.
    Mechl Z; Kadlecová D; Konecný M
    Neoplasma; 1966; 13(3):327-33. PubMed ID: 5911956
    [No Abstract]   [Full Text] [Related]  

  • 17. Results of combined modality treatment for nasopharyngeal cancer.
    Venkitaraman R; Ramanan SG; Vasanthan A; Sagar TG
    J Cancer Res Ther; 2009; 5(2):102-6. PubMed ID: 19542665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma.
    Maoleekoonpairoj S; Phromratanapongse P; Puttanuparp S
    J Med Assoc Thai; 1997 Dec; 80(12):778-84. PubMed ID: 9470331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes of patients with AJCC stage IVC nasopharyngeal carcinoma: benefits of primary radiotherapy.
    Yeh SA; Tang Y; Lui CC; Huang EY
    Jpn J Clin Oncol; 2006 Mar; 36(3):132-6. PubMed ID: 16520357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term survival following chemotherapy for recurrent head and neck cancer: patient characteristics].
    Airoldi M; Bumma C; Cortesina G; Giordano C; Bussi M; Orecchia R; Succo G; Gabriele P; Bertetto O
    Acta Otorhinolaryngol Ital; 1994; 14(6):603-9. PubMed ID: 7740960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.